<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01685099</url>
  </required_header>
  <id_info>
    <org_study_id>201207061RIC</org_study_id>
    <nct_id>NCT01685099</nct_id>
  </id_info>
  <brief_title>Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous Pleurisy</brief_title>
  <official_title>Evaluating the Diagnostic Validity of Inflammation-associated Markers for Tuberculous Pleurisy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. To investigate the difference of PE inflammation/apoptosis-associated markers between TB&#xD;
           pleurisy and non-TB pleurisy&#xD;
&#xD;
        2. To investigate the difference of neutrophil apoptosis in exudative PE between TB&#xD;
           pleurisy and non-TB pleurisy&#xD;
&#xD;
        3. To investigate the change of apoptosis pattern of PE neutrophil, before and after TB&#xD;
           antigen stimulation, and compare the difference between TB pleurisy and non-TB pleurisy&#xD;
&#xD;
        4. To investigate diagnostic aid of the inflammation/apoptosis-associated markers and&#xD;
           apoptosis pattern of PE neutrophil for tuberculous pleurisy&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tuberculosis (TB) remains a global health problem even though it has nearly been eradicated&#xD;
      in some developed countries. Because of variable manifestations and the difficulty in&#xD;
      collecting clinical samples, extra-pulmonary TB is usually difficult to early diagnose.&#xD;
      Tuberculous pleurisy (TP) is one of the most common extra-pulmonary infection and accounts&#xD;
      for approximately 5% of all forms of TB. The gold standard for diagnosing TP is mycobacterial&#xD;
      culture of pleural effusion (PE), pleura tissue, which requires weeks to yield. The treatment&#xD;
      could thus be delayed, resulting in an increased mortality rate. In addition, mycobacterial&#xD;
      culture is not so sensitive for PE and with positivity in less than two thirds of cases with&#xD;
      TB pleurisy.&#xD;
&#xD;
      For diagnosing TP, PE biomarkers are required to be investigated in addition to traditional&#xD;
      PE cell counting and biochemistry. In particularly, inflammation-associated cytokines and&#xD;
      apoptosis-associated markers may be important because the two pathways involve in TB&#xD;
      infection/defense mechanism. For inflammation-association markers, current literature is not&#xD;
      comprehensive except IFN-gamma and IFN-gamma release assay (IGRA). However, the result of&#xD;
      IGRA using PE is disappointed. We should study other PE inflammation markers such as&#xD;
      IFN-induced protein-10, interleukin [IL]-2, IL-12 and so on. On the other hand, apoptosis&#xD;
      suppression is one of escape mechanisms in TB pathogenesis. Macrophage, dendritic cell, and&#xD;
      neutrophil are reportedly inhibited for apoptosis in TB infection. But the apoptosis of PE&#xD;
      neutrophil are rarely studied. Moreover, the role of apoptosis-associated markers (Fas ligand&#xD;
      [FasL], decoy receptor 3, lipoxin, prostaglandin E2, caspases) in PE has rarely been&#xD;
      investigated in diagnosing TP except FasL. Therefore, we conduct a prospective study to&#xD;
      investigate inflammation/apoptosis-associated markers in exudative PE and apoptosis of PE&#xD;
      neutrophil to analyze their diagnostic usefulness for TP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2012</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>diagnosis of tuberculous pleurisy</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mortality</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>To Investigate Diagnostic Aid of the Inflammation and Apoptosis-associated Markers and Apoptosis Pattern of PE Neutrophil for Tuberculous Pleurisy</condition>
  <arm_group>
    <arm_group_label>Group with tuberculous pleurisy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group with non-tuberculous pleurisy</arm_group_label>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      pleural effusion&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        1. Patients with tuberculous pleural effusion&#xD;
&#xD;
          2. Patients with pleural effusion due to causes other than tuberculosis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient older than 20 years old&#xD;
&#xD;
          -  patients with exudative pleural effusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal of enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chin-Chung Shu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chin-Chung Shu, MD</last_name>
    <phone>886-972653087</phone>
    <email>ccshu139@ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chin-Chung Shu, MD</last_name>
      <phone>886972653087</phone>
      <email>ccshu139@ntu.edu.tw</email>
    </contact>
    <investigator>
      <last_name>Chin-Chung Shu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2012</verification_date>
  <study_first_submitted>September 11, 2012</study_first_submitted>
  <study_first_submitted_qc>September 11, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2012</study_first_posted>
  <last_update_submitted>September 11, 2012</last_update_submitted>
  <last_update_submitted_qc>September 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 13, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>diagnosis, inflammation-associated markers, pleural effusion, tuberculosis, tuberculous pleurisy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tuberculosis</mesh_term>
    <mesh_term>Pleurisy</mesh_term>
    <mesh_term>Tuberculosis, Pleural</mesh_term>
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

